Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/PF-03654746> ?p ?o }
Showing triples 1 to 79 of
79
with 100 triples per page.
- PF-03654746 abstract "PF-03654746 is a potent and selective histamine H3 receptor antagonist developed by Pfizer and currently undergoing clinical trials for the treatment of ADHD, Tourette syndrome as well as potential anti-allergy applications.".
- PF-03654746 iupacName "trans-N-Ethyl-3-fluoro-3-[3-fluoro-4-(1-pyrrolidinylmethyl)phenyl]cyclobutanecarboxamide".
- PF-03654746 pubchem "16119086".
- PF-03654746 thumbnail PF-03654746.svg?width=300.
- PF-03654746 wikiPageID "27917995".
- PF-03654746 wikiPageLength "3963".
- PF-03654746 wikiPageOutDegree "13".
- PF-03654746 wikiPageRevisionID "705012164".
- PF-03654746 wikiPageWikiLink Allergy.
- PF-03654746 wikiPageWikiLink Attention_deficit_hyperactivity_disorder.
- PF-03654746 wikiPageWikiLink Category:Amides.
- PF-03654746 wikiPageWikiLink Category:H3_receptor_antagonists.
- PF-03654746 wikiPageWikiLink Category:Nootropics.
- PF-03654746 wikiPageWikiLink Category:Organofluorides.
- PF-03654746 wikiPageWikiLink Category:Pfizer.
- PF-03654746 wikiPageWikiLink Category:Pyrrolidines.
- PF-03654746 wikiPageWikiLink Clinical_trial.
- PF-03654746 wikiPageWikiLink Histamine_H3_receptor.
- PF-03654746 wikiPageWikiLink Pfizer.
- PF-03654746 wikiPageWikiLink Receptor_antagonist.
- PF-03654746 wikiPageWikiLink Tourette_syndrome.
- PF-03654746 wikiPageWikiLinkText "PF-03654746".
- PF-03654746 c "18".
- PF-03654746 chemspiderid "25069700".
- PF-03654746 f "2".
- PF-03654746 h "24".
- PF-03654746 inchi "1".
- PF-03654746 inchikey "SXMBKHYDZOCBMT-PPUGGXLSBZ".
- PF-03654746 iupacName "trans-N-Ethyl-3-fluoro-3-[3-fluoro-4-phenyl]cyclobutanecarboxamide".
- PF-03654746 molecularWeight "322.392".
- PF-03654746 n "2".
- PF-03654746 o "1".
- PF-03654746 pubchem "16119086".
- PF-03654746 smiles "CCNC[C@H]1C[C@@]C2=CCF".
- PF-03654746 stdinchi "1".
- PF-03654746 stdinchikey "SXMBKHYDZOCBMT-PPUGGXLSSA-N".
- PF-03654746 verifiedrevid "451561693".
- PF-03654746 width "260".
- PF-03654746 wikiPageUsesTemplate Template:Drugbox.
- PF-03654746 wikiPageUsesTemplate Template:Histaminergics.
- PF-03654746 wikiPageUsesTemplate Template:Pharma-stub.
- PF-03654746 wikiPageUsesTemplate Template:Reflist.
- PF-03654746 subject Category:Amides.
- PF-03654746 subject Category:H3_receptor_antagonists.
- PF-03654746 subject Category:Nootropics.
- PF-03654746 subject Category:Organofluorides.
- PF-03654746 subject Category:Pfizer.
- PF-03654746 subject Category:Pyrrolidines.
- PF-03654746 hypernym Antagonist.
- PF-03654746 type ChemicalSubstance.
- PF-03654746 type Company.
- PF-03654746 type Drug.
- PF-03654746 type Group.
- PF-03654746 type Amide.
- PF-03654746 type Antagonist.
- PF-03654746 type Antihistamine.
- PF-03654746 type Chemical.
- PF-03654746 type Company.
- PF-03654746 type Group.
- PF-03654746 type Heterocycle.
- PF-03654746 type Nootropic.
- PF-03654746 type Organofluoride.
- PF-03654746 type Organohalide.
- PF-03654746 type Psychoanaleptic.
- PF-03654746 type Organofluoride.
- PF-03654746 type Organohalide.
- PF-03654746 type ChemicalObject.
- PF-03654746 type Thing.
- PF-03654746 type Q8386.
- PF-03654746 comment "PF-03654746 is a potent and selective histamine H3 receptor antagonist developed by Pfizer and currently undergoing clinical trials for the treatment of ADHD, Tourette syndrome as well as potential anti-allergy applications.".
- PF-03654746 label "PF-03654746".
- PF-03654746 sameAs Q7119047.
- PF-03654746 sameAs m.0ch3q0s.
- PF-03654746 sameAs PF-03654746.
- PF-03654746 sameAs PF-03654746.
- PF-03654746 sameAs Q7119047.
- PF-03654746 wasDerivedFrom PF-03654746?oldid=705012164.
- PF-03654746 depiction PF-03654746.svg.
- PF-03654746 isPrimaryTopicOf PF-03654746.